by Mallory Locklear, Yale University Credit: Pixabay/CC0 Public Domain Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and the University of British Columbia, however, finds that using a lower...
